SCHEMBL9100053

SCHEMBL9100053

Nc1cc(C=O)cc2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
HSD17B10 Q99714 4/20 0.45
HPGD P15428 3/20 0.45
CYP3A4 P08684 2/20 0.45
TSHR P16473 1/20 0.45
KEAP1 Q14145 1/20 0.45
HPRT1 P00492 1/20 0.42
CYP2A6 P11509 2/20 0.39
KDM4E B2RXH2 3/20 0.38
KIF11 P52732 2/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
RAD52 P43351 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
NQO1 P15559 1/20 0.37
HIF1A Q16665 1/20 0.37
CYP1B1 Q16678 1/20 0.37
ERN1 O75460 2/20 0.37
CYP1A2 P05177 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746125 0.85 ALDH1A1 (0.37) ALDH1A1HSD17B10HPGDCYP3A4TSHR
SCHEMBL29951355 0.78 ALDH1A1 (0.48) ALDH1A1HSD17B10HPGDCYP3A4TSHR
SCHEMBL2996328 0.78 ERN1 (0.45) ALDH1A1HSD17B10HPGDCYP2A6KDM4E
SCHEMBL6362144 0.78 CYP1A2 (0.57) ALDH1A1HSD17B10HPGDTSHRCYP2A6
SCHEMBL31141573 0.78 ERN1 (0.45) ALDH1A1HSD17B10HPGDCYP2A6KDM4E
SCHEMBL29951294 0.78 CYP1A2 (0.57) ALDH1A1HSD17B10HPGDTSHRCYP2A6
SCHEMBL6200530 0.76 NQO2 (0.55) ALDH1A1HSD17B10HPGDCYP2A6KDM4E
SCHEMBL7841913 0.76 ALDH1A1 (0.47) ALDH1A1HSD17B10CYP2A6KIF11NPC1
SCHEMBL29952947 0.76 HPRT1 (0.42) ALDH1A1HSD17B10HPGDCYP3A4TSHR
SCHEMBL1775016 0.76 ALDH1A1 (0.41) ALDH1A1HSD17B10HPGDCYP3A4CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0486478-A2 Renin-inhibiting peptides THE UPJOHN COMPANY (US) 1992-05-20 EP disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180897-B1 5-FLUOROURACIL DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-07 EP disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 US disclosed
US-4880781-A HYPOTENSIVE AGENTS THE UPJOHN COMPANY (US) 1989-11-14 US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed
EP-0173481-A2 Peptides THE UPJOHN COMPANY (US) 1986-03-05 EP disclosed